Stifel Financial’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
FCM
AIM
AVM
NAMA
Stifel Financial's BEAM Position: Q2 2026 in Review
Stifel Financial increased its Beam Therapeutics (BEAM) stake by 37% in Q2 2026, buying an estimated $138K and bringing the position to 16,979 shares worth $583K. The position accounts for ﹤0.01% of the portfolio, ranked #2882.
Stifel Financial first reported a position in BEAM in Q3 2021 and has held it in 16 quarters since. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.
- Stifel Financial held 16,979 shares of Beam Therapeutics worth $583K as of Q2 2026.
- Stifel Financial bought 4,564 Beam Therapeutics shares in Q2 2026, an estimated $138K.
- Beam Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2882 holding.
- Stifel Financial first reported a position in Beam Therapeutics in Q3 2021 and has held it in 16 quarters since.
- 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.
Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.